Go to:
Logótipo
Você está em: Start > Publications > View > Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents
Publication

Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents

Title
Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents
Type
Article in International Scientific Journal
Year
2020
Authors
Alves, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Serrano, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rodrigues, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pinteus, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gaspar, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Botana, LM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Alpoim, MC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pedrosa, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Journal
Vol. 128
ISSN: 0753-3322
Publisher: Elsevier
Other information
Authenticus ID: P-00S-5VG
Abstract (EN): Cancer is one of the major threats to human health and, due to distinct factors, it is expected that its incidence will increase in the next decades leading to an urgent need of new anticancer drugs development. Ongoing experimental and clinical observations propose that cancer cells with stem-like properties (CSCs) are involved on the development of lung cancer chemoresistance. As tumour growth and metastasis can be controlled by tumour-associated stromal cells, the main goal of this study was to access the antitumor potential of five bromoterpenes isolated from Sphaerococcus coronopifolius red alga to target CSCs originated in a co-culture system of fibroblast and lung malignant cells. Cytotoxicity of compounds (10-500 mu M; 72 h) was evaluated on monocultures of several malignant and non-malignant cells lines (HBF, BEAS-2B, RenG2, SC-DRenG2) and the effects estimated by MIT assay. Co-cultures of non-malignant human bronchial fibroblasts (HBF) and malignant human bronchial epithelial cells (RenG2) were implemented and the compounds ability to selectively kill CSCs was evaluated by sphere forming assay. The interleucine-6 (IL-6) levels were also determined as cytokine is crucial for CSCs. Regarding the monocultures results bromosphaerol selectively eliminated the malignant cells. Both 12S-hydroxy-bromosphaerol and 12R-hydroxy-bromosphaerol steroisomers were cytotoxic towards non-malignant bronchial BEAS-2B cell line, IC50 of 4.29 and 4.30 mu M respectively. However, none of the steroisomers induced damage in the HBF5. As to the co-cultures, 12R-hydroxy-bromosphaerol revealed the highest cytotoxicity and ability to abrogate the malignant stem cells; however its effects were IL-6 independent. The results presented here are the first evidence of the potential of these bromoterpenes to abrogate CSCs opening new research opportunities. The 12R-hydroxy-bromosphaerol revealed to be the most promising compound to be test in more complex living models.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Tramadol hydrochloride: Pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems (2015)
Another Publication in an International Scientific Journal
Vazzana, M; Andreani, T; Fangueiro, J; Faggio, C; Silva, C; Santini, A; Garcia, ML; Silva, AM; Souto, EB
Biosynthetic versatility of marine-derived fungi on the delivery of novel antibacterial agents against priority pathogens (2021)
Another Publication in an International Scientific Journal
Gomes, NGM; Madureira Carvalho, AA; Dias da Silva, D; Patricia Valentao; Paula B Andrade
Ultrasonographic, thermographic and histologic evaluation of MNU-induced mammary tumors in female Sprague-Dawley rats (2013)
Article in International Scientific Journal
A. I. Faustino Rocha; A. Silva; J. Gabriel ; C. I. Teixeira Guedes; C. Lopes; R. Gil da Costa; A. Gama; R. Ferreira; P. A. Oliveira; M. Ginja
Two cinnamic acid derivatives as inhibitors of Pseudomonas aeruginosa las and pqs quorum-sensing systems: Impact on biofilm formation and virulence factors (2025)
Article in International Scientific Journal
Anabela Borges; Miguel M. Leitão; Ariana S.C. Gonçalves; Sérgio Sousa; Fernanda Borges; Simões M
Protective effects of a blueberry extract in acute inflammation and collagen-induced arthritis in the rat (2016)
Article in International Scientific Journal
Figueira, ME; Oliveira, M; Direito, R; Rocha, J; Alves, P; Serra, AT; Duarte, C; Bronze, R; Fernandes, A; Brites, D; Freitas, M; Eduarda Fernandes; Sepodes, B

See all (20)

Recommend this page Top
Copyright 1996-2026 © Faculdade de Farmácia da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2026-02-19 at 15:30:33 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book